Literature DB >> 21809147

[New developments in MRI of the liver].

N Bastati-Huber1, H Prosch, S Baroud, S Magnaldi, W Schima, A Ba-Ssalamah.   

Abstract

Radiology has gained an exceptional position in medicine because a correct diagnosis is the most crucial issue in determining an accurate and personalized therapeutic strategy. This has a direct influence not only on the individual patient but also on the socio-economic aspects of healthcare services in terms of shortening the time interval to establish a diagnosis and to avoid risk-associated invasive diagnostic methods or long-term, cost-intensive follow-up. Magnetic resonance imaging (MRI) is an excellent example of this which due to continuous technological developments and emerging techniques allows a non-invasive diagnosis of the different hepatic diseases. In this article, we illustrate the direct correlation between the recent technical advances in MRI, such as 3.0 T, diffusion-weighted imaging, perfusion imaging, spectroscopy, texture analysis and MR elastography and obtaining a confident non-invasive diagnosis of focal and diffuse liver diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809147     DOI: 10.1007/s00117-010-2126-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  38 in total

Review 1.  [Modern visualization of the liver with MRT. Current trends and future perspectives].

Authors:  C J Zech; S O Schoenberg; K A Herrmann; O Dietrich; M I Menzel; T Lanz; A Wallnöfer; T Helmberger; M F Reiser
Journal:  Radiologe       Date:  2004-12       Impact factor: 0.635

Review 2.  Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review.

Authors:  Frank Fischbach; Harald Bruhn
Journal:  Liver Int       Date:  2008-03       Impact factor: 5.828

Review 3.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

Review 4.  Body MR imaging at 3.0 T: understanding the opportunities and challenges.

Authors:  Mara M Barth; Martin P Smith; Ivan Pedrosa; Robert E Lenkinski; Neil M Rofsky
Journal:  Radiographics       Date:  2007 Sep-Oct       Impact factor: 5.333

5.  Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.

Authors:  Hyo Jung Seo; Myeong-Jin Kim; Jong Doo Lee; Woo-Suk Chung; Yeo-Eun Kim
Journal:  Invest Radiol       Date:  2011-09       Impact factor: 6.016

6.  Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.

Authors:  Victoria Chernyak; Jane Kim; Alla M Rozenblit; Fernanda Mazzoriol; Zina Ricci
Journal:  J Magn Reson Imaging       Date:  2011-05-23       Impact factor: 4.813

7.  Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.

Authors:  Yingbing Wang; Tarik K Alkasab; Ozden Narin; Rosalynn M Nazarian; Rathachai Kaewlai; Jonathan Kay; Hani H Abujudeh
Journal:  Radiology       Date:  2011-05-17       Impact factor: 11.105

8.  Assessment of diffusion-weighted MR imaging in liver fibrosis.

Authors:  Laurence Annet; Frank Peeters; Jorge Abarca-Quinones; Isabelle Leclercq; Pierre Moulin; Bernard E Van Beers
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

9.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

10.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

View more
  3 in total

1.  [Focal nodular hyperplasia and hepatocellular adenoma].

Authors:  N Bastati-Huber; S Pötter-Lang; A Ba-Ssalamah
Journal:  Radiologe       Date:  2015-01       Impact factor: 0.635

2.  [Oncologic imaging: indications for and limitations of modern cross-sectional imaging techniques].

Authors:  M E Mayerhoefer; A Ba-Ssalamah; H Prosch
Journal:  Radiologe       Date:  2013-04       Impact factor: 0.635

3.  Liver unidentified bright object in a septic patient.

Authors:  Daniel Peternac; Michael Andreas Patak; Christoph Gubler
Journal:  Case Rep Gastroenterol       Date:  2013-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.